Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.


Listen to the latest hemonc news from international experts

Focus on ALL: treating older patients, Ph-like ALL & post-transplant interventions

Advances in both the treatment landscape and the pathology of the disease have improved the outcome of children and adults with acute lymphoblastic leukemia (ALL). However, many challenges still remain, including the treatment of older patients with ALL, diagnosis of Philadelphia chromosome-like (Ph-like) ALL, a newly identified aggressive subtype, as well as the evolving role of hematopoietic stem cell transplantation.

In this exclusive podcast, VJHemOnc spoke with Selina Luger, MD, of the University of Pennsylvania, Philadelphia, PA, Sarah Tasian, MD, from The Children’s Hospital of Philadelphia, Philadelphia, PA and David Marks, MBBS, PhD, FRACP, FRCPath, of the University Hospitals Bristol NHS Foundation Trust, Bristol, UK, who discuss the challenges in managing older patients with ALL, diagnostic testing modalities for Ph-like ALL and post-allogeneic stem cell transplantation interventions to prevent and treat relapse in patients.

Date: 28th May 2021

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter